Efficacy of dexmedetomidine added to ropivacaine for superior trunk of brachial plexus block and superficial cervical plexus block by ultrasound-guided in arthroscopic shoulder surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16009843

Enrollment

Unknown

Registered

2016-11-14

Start date

2016-11-10

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury of Rotator Cuff

Interventions

D group:0.35% ropivacaine

E group:0.35% ropivacaine and 1ug/kg dexmedetomidine

Eligibility

Sex/Gender

All

Age

45 Years to 75 Years

Inclusion criteria

Inclusion criteria: Elective patients under arthroscopic shoulder rotator cuff repair, ASAI-II, male or female aged 45 to 75 years old

Exclusion criteria

Exclusion criteria: Severe heart diseases, lung diseases, brain diseases or complications, liver dysfunction and kidney dysfunction, coagulant dysfunction.

Design outcomes

Primary

Measure	Time frame
blood pressure;heart rate;dosage of opioids;dosage of sevoflurane;VAS scores at 6h after the surgery, 12h after the surgery;	—

Secondary

Measure	Time frame
age;the operation time;extubation time;BMI;	—

Countries

China

Contacts

Public ContactSun Shi-yu

Shanghai Tenth People's Hospital, Tongji University School of Medicine

sunshiyu0407@126.com+86 17721325518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026